Blog
3 Coronavirus Vaccines in Phase 3 Clinical Studies: How They Stack Up Against Each Other
Any way you look at it, the numbers related to coronavirus vaccine candidates in development are impressive. In less than nine months, researchers have advanced 180 experimental coronavirus vaccines
Trump's 3 Most Ridiculous Social Security Ideas
For more than 80 years, Social Security has been providing a financial foundation for our nation's retired workers who can no longer provide for themselves. It's arguably our country's most
3 Cheap Stocks You Can Buy and Hold for Decades
Even with the recent pullback, the stock market remains near all-time highs. There aren't many stocks with attractive valuations. Of those, quite a few aren't the kinds of stocks you'd want to touch
Citigroup Has to Answer an Important Question for Investors -- and Regulators
Everyone makes mistakes, including big corporations. Unfortunately, when the largest global banks make them, those mistakes tend to have a lot of zeroes after them and create all sorts of
Got $300? 4 Great Stocks to Buy in a Volatile Market
Investing in 2020 has been challenging, to say the least. In a roughly six-month stretch, the stock market plunged at a faster pace than ever before, as well as rebounded to new highs more quickly
The Top 2 IPO Stocks to Avoid This September
Two of the hottest IPO stocks investors are talking about in September are coronavirus vaccine developer CureVac (NASDAQ: CVAC) and cloud-data giant Snowflake (NYSE: SNOW). In a short amount of
5-Stock Recommendations Review, Five Years Later
In this episode of Rule Breaker Investing: Review-a-palooza! The Motley Fool co-founder David Gardner is joined by The Motley Fool's Maria Gallagher to review 10 stock recommendations from past
Abbott Launches World's First Glucose Monitor for Athletes
Glucose biosensors are typically used by people with diabetes to track their blood sugar levels while avoiding traditional finger-stick tests that accomplish the same goal.
Abbott Laboratories
Curaleaf Hires a New Retail Chief
Curaleaf Holdings (OTC: CURLF) has replaced one of its key executives. The company announced Thursday that it has named Talley Wettlaufer to the position of senior vice president of retail --
Beyond Coronavirus: Moderna Teams Up With Vertex on Cystic Fibrosis Therapy
All eyes are on Moderna's (NASDAQ: MRNA) coronavirus vaccine, but the biotech is looking ahead, setting up a new research collaboration with Vertex Pharmaceuticals (NASDAQ: VRTX) to develop a
Why Snowflake Stock Fell Today
Shares of Snowflake (NYSE: SNOW) declined by 10.4% on Thursday, giving back some of the cloud-based data management company's first-day gains.
To say Snowflake had a blockbuster initial public
Why Moderna Was So Volatile on Thursday
Moderna (NASDAQ: MRNA) was a roller-coaster stock on Thursday, at one point trading 3% higher, then as much as 6% lower, before settling in for a 1.3% loss at the end of the day.
A business update
Walmart Responds to Changing Retail Structure, Increased Pickup and Delivery With Pay Hikes
Walmart (NYSE: WMT) announced in a press release today it's boosting the pay of approximately 165,000 of its associates. It has slated increases not only to hourly minimums but to the possible pay
Report: Walmart India Unit Flipkart to Launch IPO
Flipkart, the prominent e-tailer based in India that is owned by Walmart (NYSE: WMT), is preparing for an initial public offering (IPO). That's according to an article published Wednesday by
Why Kodak Stock Soared Today
Shares of Eastman Kodak (NYSE: KODK) surged 25.6% on Thursday, furthering the stock's rebound following its internal investigation of the events surrounding its loan award from the U.S. government.
CME Group Launching "First-of-its-Kind" Water Futures Product
Investors can buy and sell futures contracts for items like pork bellies and oil, so why not for water too? Securities exchange operator CME Group (NASDAQ: CME), which specializes in financial
New York Files Charges Against Johnson & Johnson Over Opioid Marketing
New York's Department of Financial Services filed civil charges against Johnson & Johnson (NYSE: JNJ) on Thursday, accusing the biopharmaceutical giant of downplaying the risks to patients
S&P 500 Falls as Fed Fears, Unemployment Rattle Investors, Sending Amazon, Retail, Real Estate Stocks Down
The streak is going in the other direction now. After yesterday's S&P 500 Index (SNPINDEX: ^GSPC) 16-point sell-off ended a multi-day streak of gains, today's 0.85% decline will be just the second
Can the Fed Save the Stock Market Again?
Thursday was a turbulent day on Wall Street, with stocks seeing a lot of movement. After an initial loss, major market benchmarks clawed back most of what they'd lost, with the Dow Jones Industrial
Trulieve Cannabis Expands Into Fifth State with a Pair of Acquisitions
Trulieve Cannabis (OTC: TCNNF) is venturing quite some distance from its home base of Florida with its latest acquisitions. It announced Wednesday that it has purchase two companies in Pennsylvania
BioNTech Buys a Plant to Manufacture Its Coronavirus Vaccine
BioNTech (NASDAQ: BNTX) and Pfizer (NYSE: PFE) haven't even released phase 3 clinical trial data for their coronavirus vaccine, BNT162b2, but BioNTech is already preparing to ramp up production next
Why Forterra's Shares Plunged 14.4% on Thursday
Shares of Forterra (NASDAQ: FRTA) plunged as much as 14.4% in trading Thursday after announcing the pricing of a stock sale. The stock didn't recover much from lows and was still down 11.8% for the
Why Penn National Gaming Stock Jumped Today
Shares of Penn National Gaming (NASDAQ: PENN) climbed 7.6% on Thursday, following positive analyst commentary.
Stifel analyst Steven Wieczynski reiterated his buy rating on Penn's shares and boosted
Baozun Launches IPO in Hong Kong
Baozun (NASDAQ: BZUN) is sticking to its home region for its latest round of capital raising. The Shanghai-based e-commerce company announced Thursday that it has launched an initial public offering
Bristol-Myers Squibb Cuts Deal, Delaying Threat to Top-Selling Revlimid
Bristol-Myers Squibb (NYSE: BMY) is granting Dr. Reddy's Laboratories (NYSE: RDY) a volume-limited license to produce a generic version of its blockbuster multiple myeloma drug, Revlimid, beginning


